SoMCC Event
Title: |
Industry Insights: Amyris Biotechnologies (Sr. VP Development and Co-founder) |
|
| Date: | Tuesday, December 11, 2007 | |
| Time: | 12:00 -1:15 PM (Presentation, Panel, and Q&A) 1:15-1:30 PM (Networking reception & light refreshments) |
|
| Location: | Clark Center Auditorum |
|
| Sponsors: | School of Medicine Career Center (SoMCC) and PAC |
|
| Event details: | Global climate change and petroleum reserve depletion have driven the
need to develop alternative methods of producing fuels and chemical
feedstocks. Clearly, these are major challenges of this century. Current standards and approaches to energy production represent a
serious threat to the health of our planet and life as we know it;
from a market perspective, this has led to the emergence of the
clean-tech industry. Not surprisingly, the complexity of the
challenges this industry faces requires the cooperation and
collaboration of experts from many fields, biology, life science, and
engineering chief among them.
ABOUT the SPEAKER(S) Neil Renninger, Ph.D. is SVP, Development, and co-founder of Amyris. He earned his PhD in Chemical Engineering at UC Berkeley focusing on the metabolic engineering of bacterial cells for chemical transformations, and a BS in Chemical Engineering and M.S. in Environmental Engineering at MIT. Earlier this year, Neil was named one of the Top 35 Innovators under 35 by Technology Review. Panelists: Arle Kruckeberg, Ph.D., Senior Scientist, Strain Engineering Kirsten Benjamin, Ph.D., Scientist, Artemisinin Gale Wichman, Ph.D., Scientist, Molecular Biology Zach Serber, Ph.D., Scientist, Fuels and Artemisinin Salvador Rivera, Human Resources and Recruiting |
|
| Fee: | Free and open to Stanford ID holders. |
|
| Additional information and/or registration: | RSVP: Required, http://reggie.stanford.edu/signup.asp?1701 |

